Ignite Creation Date:
2024-05-06 @ 2:15 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04262089
Status:
COMPLETED
Last Update Posted:
2023-12-05
First Post:
2020-01-28
Brief Title:
Neo-adjuvant Pembrolizumab in dMMR POLE-EDM Uterine Cancer Patients a Feasibility Study
Sponsor:
University Medical Center Groningen
Organization:
University Medical Center Groningen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-28
First Submit QC Date:
February 5 2020
Study First Post Date:
2020-02-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-04
Last Update Post Date:
2023-12-05
Last Update Post Date Type:
ACTUAL